Overall, these findings provide a mechanism that includes interactions among excess body fat, inflammation, metabolic dysfunction, and aromatase in the breast that help to explain why excess body fat is likely to increase the penetrance of breast cancer in BRCA1 and BRCA2 mutation carriers. The gene discussed is CYP19A1; the disease is breast carcinoma.